论文部分内容阅读
目的观察雷贝拉唑+阿莫西林克拉维酸钾+甲硝唑三联疗法治疗消化性溃疡的临床效果。方法选取消化性溃疡患者76例,随机分为观察组和对照组各38例,对照组单用雷贝拉唑治疗,观察组给予雷贝拉唑+阿莫西林克拉维酸钾+甲硝唑三联疗法,比较2组临床治疗效果。结果观察组总有效率为94.74%,高于对照组的76.32%,差异有统计学意义(χ~2=5.2084,P<0.05)。结论雷贝拉唑+阿莫西林克拉维酸钾+甲硝唑三联疗法治疗消化性溃疡效果显著,能进一步改善病情,可推荐。
Objective To observe the clinical efficacy of rabeprazole + amoxicillin and clavulanate + metronidazole triple therapy in the treatment of peptic ulcer. Methods 76 patients with peptic ulcer were randomly divided into observation group and control group, 38 cases in each group. The control group was treated with rabeprazole alone. The observation group was given rabeprazole + amoxicillin potassium clavulanate + metronidazole Triple therapy, comparing two groups of clinical treatment. Results The total effective rate in observation group was 94.74%, which was higher than that in control group (76.32%), the difference was statistically significant (χ ~ 2 = 5.2084, P <0.05). Conclusion Rabeprazole + amoxicillin and clavulanate potassium + metronidazole triple therapy in the treatment of peptic ulcer effect is significant, can further improve the condition, can be recommended.